Literature DB >> 9113602

Lost workdays and decreased work effectiveness associated with headache in the workplace.

B S Schwartz1, W F Stewart, R B Lipton.   

Abstract

Little is known about the impact of different types of headache on lost work time and work effectiveness in the United States. Estimation of the distribution and magnitude of the impact of headache in the workplace is necessary before workplace interventions can be developed. During 1993 and 1994 in Baltimore County, Maryland, study subjects were contacted by random-digit dialing and interviewed by telephone about their headaches. Headache diagnoses were assigned using International Headache Society criteria for migraine and episodic tension-type headache. Measures of workplace impact were derived based on self-reports of missing work because of headache and frequency and magnitude of reduced work level because of headache. Of the 13,343 respondents, 9.4% reported missing work more than rarely because of headache, 31% reported that their work level was reduced more than rarely by headache, and 9.2% reported that their work level was reduced more than 50% by headaches during work. In accounting for both actual lost workdays and reduced effectiveness at work, individuals lost the equivalent of 4.2 days per year because of headache. Of the 9922 annual estimated actual lost workdays because of headache, 57% were due to migraine and 43% were due to tension-type and other headache types. Of the 23,287 annual estimated reduced effectiveness workday equivalents, 64% were due to tension-type and other headache types, and 36% were due to migraine. Headache type, headache severity, and education level were each independent predictors of workplace impact of headache. Subjects with migraine headache were much more likely to report actual lost workdays because of headache, whereas tension-type and other headache types accounted for a large proportion of decreased work effectiveness because of headache. The results have implications regarding the control of indirect costs in the workplace because of headache, and on workplace-based treatment and prevention programs.

Entities:  

Mesh:

Year:  1997        PMID: 9113602     DOI: 10.1097/00043764-199704000-00009

Source DB:  PubMed          Journal:  J Occup Environ Med        ISSN: 1076-2752            Impact factor:   2.162


  32 in total

Review 1.  Central and peripheral sensitization in tension-type headache.

Authors:  Lars Bendtsen
Journal:  Curr Pain Headache Rep       Date:  2003-12

2.  Validation of the work and health interview.

Authors:  Walter F Stewart; Judith A Ricci; Carol Leotta; Elsbeth Chee
Journal:  Pharmacoeconomics       Date:  2004       Impact factor: 4.981

Review 3.  Employee health and presenteeism: a systematic review.

Authors:  Alyssa B Schultz; Dee W Edington
Journal:  J Occup Rehabil       Date:  2007-07-25

Review 4.  Tension-type headache.

Authors:  Elizabeth Loder; Paul Rizzoli
Journal:  BMJ       Date:  2008-01-12

Review 5.  The impact of migraine and the effect of migraine treatment on workplace productivity in the United States and suggestions for future research.

Authors:  Wayne N Burton; Stephen H Landy; Kristen E Downs; M Chris Runken
Journal:  Mayo Clin Proc       Date:  2009-05       Impact factor: 7.616

Review 6.  The cost and impact of health conditions on presenteeism to employers: a review of the literature.

Authors:  Alyssa B Schultz; Chin-Yu Chen; Dee W Edington
Journal:  Pharmacoeconomics       Date:  2009       Impact factor: 4.981

Review 7.  The role of muscles in tension-type headache.

Authors:  Lars Bendtsen; César Fernández-de-la-Peñas
Journal:  Curr Pain Headache Rep       Date:  2011-12

Review 8.  Workplace productivity. A review of the impact of migraine and its treatment.

Authors:  P Stang; R Cady; A Batenhorst; L Hoffman
Journal:  Pharmacoeconomics       Date:  2001       Impact factor: 4.981

9.  Two double-blind, multicenter, randomized, placebo-controlled, single-dose studies of sumatriptan/naproxen sodium in the acute treatment of migraine: function, productivity, and satisfaction outcomes.

Authors:  Stephen Landy; Sarah E DeRossett; Alan Rapoport; John Rothrock; Michael H Ames; Susan A McDonald; Steven P Burch
Journal:  MedGenMed       Date:  2007-06-07

10.  The burden of migraine in Spain: beyond direct costs.

Authors:  Xavier Badia; Sol Magaz; Laura Gutiérrez; Jordi Galván
Journal:  Pharmacoeconomics       Date:  2004       Impact factor: 4.981

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.